Molecular characterization of a Chinese woman homozygous for the familial hypercholesterolemia LDLR c.1474G>A (p.Asp492Asn) mutation

References

• Goldstein J, Hobbs H, Brown M. Familial hypercholesterolemia, the Metabolic and Molecular Basis of Inherited Disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (Eds). McGraw-Hill, NY, USA (2001).
   Google Scholar
• Usifo E, Leigh SE, Whittall RA et al. Low‐density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment. Ann. Hum. Genet. 76, 387–401 (2012).
   Google Scholar
• Seftel HC, Baker SG, Sandler MP et al. A host of hypercholesterolaemic homozygotes in South Africa. Br. Med. J. 281, 633–636 (1980).
   Google Scholar
• Steyn K, Goldberg Y, Kotze M et al. Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations. Hum. Genet. 98, 479–484 (1996).
   Google Scholar
• Liyanage KE, Burnett JR, Hooper AJ, Van Bockxmeer FM. Familial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution. Crit. Rev. Clin. Lab. Sci. 48(1), 1–18 (2011).
   Google Scholar
• Raal FJ, Santos RD. Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment. Atherosclerosis 223(2), 262–268 (2012). •• This recent review provides the current outlook on the diagnosis and treatment of homozygous familial hypercholesterolemia.
   Google Scholar
• Kirin M, Mcquillan R, Franklin CS, Campbell H, Mckeigue PM, Wilson JF. Genomic runs of homozygosity record population history and consanguinity. PLoS ONE 5, e13996 (2010).
   Google Scholar
• Mcquillan R, Leutenegger A-L, Abdel-Rahman R et al. Runs of homozygosity in European populations. Am. J. Hum. Genet. 83, 359–372 (2008).
   Google Scholar
• Sund KL, Zimmerman SL, Thomas C et al. Regions of homozygosity identified by SNP microarray analysis aid in the diagnosis of autosomal recessive disease and incidentally detect parental blood relationships. Genet. Med. 15, 70–78 (2012). • Highlights the clinical utility of runs of homozygosity in the human genome and their ethical implications with parental blood relationships.
   Google Scholar
• Schaaf C, Scott D, Wiszniewska J, Beaudet A. Identification of incestuous parental relationships by SNP-based DNA microarrays. Lancet 377, 555–556 (2011).
   Google Scholar
• Ku CS, Naidoo N, Teo SM, Pawitan Y. Regions of homozygosity and their impact on complex diseases and traits. Hum. Genet. 129, 1–15 (2011). • Provides insight into identifying genetic susceptibility loci harboring recessive variants for complex diseases and traits using runs of homozygosity.
   Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972).
   Google Scholar
• Wall JD, Pritchard JK. Haplotype blocks and linkage disequilibrium in the human genome. Nat. Rev. Genet. 4, 587–597 (2003).
   Google Scholar
• Faiz F, Hooper AJ, Van Bockxmeer FM. Molecular pathology of familial hypercholesterolemia, related dyslipidemias and therapies beyond the statins. Crit. Rev. Clin. Lab. Sci. 49, 1–17 (2012).
   Google Scholar
• Jeon H, Meng W, Takagi J, Eck MJ, Springer TA, Blacklow SC. Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair. Nat. Struct. Mol. Biol. 8, 499–504 (2001).
   Google Scholar
• Adzhubei IA, Schmidt S, Peshkin L et al. A method and server for predicting damaging missense mutations. Nat. Methods 7(4), 248–249 (2010).
   Google Scholar
• Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat. Methods 7(8), 575–576 (2010).
   Google Scholar
• Amsellem S, Briffaut D, Carrié A et al. Intronic mutations outside of Alu-repeat-rich domains of the LDL receptor gene are a cause of familial hypercholesterolemia. Hum. Genet. 111, 501–510 (2002).
   Google Scholar
• Damgaard D, Larsen ML, Nissen PH et al. The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population. Atherosclerosis 180, 155–160 (2005).
   Google Scholar
• Taylor A, Tabrah S, Wang D et al. Multiplex ARMS analysis to detect 13 common mutations in familial hypercholesterolaemia. Clin. Genet. 71, 561–568 (2007).
   Google Scholar
• Mak YT, Pang CP, Tomlinson B et al. Mutations in the low-density lipoprotein receptor gene in Chinese familial hypercholesterolemia patients. Arterioscler. Thromb. Vasc. Biol. 18(10), 1600–1605 (1998).
   Google Scholar
• Pimstone SN, Sun X-M, Du Souich C, Frohlich JJ, Hayden MR, Soutar AK. Phenotypic variation in heterozygous familial hypercholesterolemia a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada. Arterioscler. Thromb. Vasc. Biol. 18, 309–315 (1998). • Shows that non-genetic factors influence the phenotype in heterozygous familial hypercholesterolemia.
   Google Scholar
• Sun X, Patel D, Webb J et al. Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype. Arterioscler. Thromb. Vasc. Biol. 14, 85–94 (1994).
   Google Scholar
• Mackey R, Venkitachalam L, Sutton-Tyrrell K. Calcifications, arterial stiffness and atherosclerosis. Adv. Cardiol. 44, 234–244 (2007).
   Google Scholar
• Alonso R, Mata N, Castillo S et al. Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors. Atherosclerosis 200(2), 315–321 (2008).
   Google Scholar
• Jansen AC, Van Aalst-Cohen ES, Tanck MW et al. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients. J. Intern. Med. 256(6), 482–490 (2004).
   Google Scholar
• Talmud PJ, Shah S, Whittall R et al. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study. Lancet 381(9874), 1293–1301 (2013).
   Google Scholar
• Brahm A, Hegele RA. Hypertriglyceridemia. Nutrients 5, 981–1001 (2013).
   Google Scholar
• Anand SS, Xie C, Paré G et al. Genetic variants associated with myocardial infarction risk factors in over 8000 individuals from five ethnic groups: the INTERHEART Genetics Study. Circ. Cardiovasc. Genet. 2, 16–25 (2009).
   Google Scholar
• Kathiresan S, Willer CJ, Peloso GM et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56–65 (2008).
   Google Scholar
• Teslovich TM, Musunuru K, Smith AV et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713 (2010).
   Google Scholar
• Woods CG, Cox J, Springell K et al. Quantification of homozygosity in consanguineous individuals with autosomal recessive disease. Am. J. Hum. Genet. 78, 889–896 (2006).
   Google Scholar
• Broman KW, Weber JL. Long homozygous chromosomal segments in reference families from the centre d’Etude du polymorphisme humain. Am. J. Hum. Genet. 65, 1493–1500 (1999).
   Google Scholar
• Pemberton TJ, Absher D, Feldman MW, Myers RM, Rosenberg NA, Li JZ. Genomic patterns of homozygosity in worldwide human populations. Am. J. Hum. Genet. 91, 275–292 (2012).
   Google Scholar
• Keller MC, Simonson MA, Ripke S et al. Runs of homozygosity implicate autozygosity as a schizophrenia risk factor. PLoS Genet. 8, e1002656 (2012).
   Google Scholar
• Eden ER, Naoumova RP, Burden JJ, Mccarthy MI, Soutar AK. Use of homozygosity mapping to identify a region on chromosome 1 bearing a defective gene that causes autosomal recessive homozygous hypercholesterolemia in two unrelated families. Am. J. Hum. Genet. 68(3), 653–660 (2001).
   Google Scholar
• National Centre for Biotechnology Information database. www.ncbi.nlm.nih.gov/genome/sts/sts.cgi?uid=11821
   Google Scholar